Austin, TX – January 2, 2024 – CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave Evans who will be transitioning into retirement after decades of outstanding service to CDISC.
Keep up to date with the latest developments at CDISC and follow our news feeds!
The European Organisation for Research and Treatment of Cancer (EORTC) is pleased to announce a new collaboration with CDISC, a leading provider of data standards in clinical research.
With its Quality of Life measures, EORTC provides the wide research community with questionnaires through which health-related quality of life of cancer patients and survivors can be assessed and their experience put at the forefront.
Philadelphia, PA and Austin, TX - 21 June 2023 - Myota, a prominent data protection platform provider, is excited to announce its newest customer, CDISC, a global standards development organization that serves the clinical research industry.
Ann Arbor, MI. and Austin, TX — 6 June 2023 —A structured, harmonized, digitized protocol accessible to the biopharmaceutical industry and to researchers in the care setting will enable transformations to improve clinical research. The project announced by HL7 Vulcan and CDISC will build on work products of ICH M11 to accelerate this vision.
CDISC invites you to an FDA-hosted public broadcast during the SEND Team’s fall virtual meetings. The broadcast is an opportunity for stakeholders to stay informed on what’s going on with the development of SEND and its use in regulatory submissions, as well as hear from our global SEND user community.
18 October 2023 10:00 – 11:30 am EDT
Austin, TX and Boston, MA – 24 Mar 2023 – Clinical research is essential for the discovery of new treatments and medical interventions that advance public health and medicine. Yet clinical research is complex, and scientific concepts are often complicated to explain.